Evidence map›Paper›PMID 28356284›Full record

ArticleAmerican journal of physiology. Renal physiology2017

Monophosphoryl lipid A induces protection against LPS in medullary thick ascending limb through a TLR4-TRIF-PI3K signaling pathway.

Bruns A Watts, Thampi George, Edward R Sherwood, David W Good

Abstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Innate Immune Memory and the Host Response to Infection.Journal of immunology (Baltimore, Md. : 1950) · 2022
    Review
  10. Article
  11. Article
  12. Exploration of Pattern Recognition Receptor Agonists as Candidate Adjuvants.Frontiers in cellular and infection microbiology · 2021
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Bruns A WattsDepartment of Internal Medicine, The University of Texas Medical Branch, Galveston, Texas.
Thampi GeorgeDepartment of Internal Medicine, The University of Texas Medical Branch, Galveston, Texas.
Edward R SherwoodDepartment of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee.
David W GoodDepartment of Internal Medicine, The University of Texas Medical Branch, Galveston, Texas; dgood@utmb.edu.
The University of Texas Medical Branch at Galveston · USVanderbilt University Medical Center · US

Funding

REGULATION OF THICK ASCENDING LIMB ACID-BASE TRANSPORTR01DK038217 · NIDDK · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI GOOD, DAVID WILLIAM · 1987 to 2019
$5.0M
NIDDK NIH HHS R01 DK038217
6 · The paper itself

Abstract

Monophosphoryl lipid A (MPLA) is a detoxified derivative of LPS that induces tolerance to LPS and augments host resistance to bacterial infections. Previously, we demonstrated that LPS inhibits [Formula: see text] absorption in the medullary thick ascending limb (MTAL) through a basolateral Toll-like receptor 4 (TLR4)-myeloid differentiation factor 88 (MyD88)-ERK pathway. Here we examined whether pretreatment with MPLA would attenuate LPS inhibition. MTALs from rats were perfused in vitro with MPLA (1 µg/ml) in bath and lumen or bath alone for 2 h, and then LPS was added to (and MPLA removed from) the bath solution. Pretreatment with MPLA eliminated LPS-induced inhibition of [Formula: see text] absorption. In MTALs pretreated with MPLA plus a phosphatidylinositol 3-kinase (PI3K) or Akt inhibitor, LPS decreased [Formula: see text] absorption. MPLA increased Akt phosphorylation in dissected MTALs. The Akt activation was eliminated by a PI3K inhibitor and in MTALs from TLR4

Indexed as

Adaptor Proteins, Vesicular TransportAnimalsBicarbonatesCytoprotectionExtracellular Signal-Regulated MAP KinasesIn Vitro TechniquesLipid ALipopolysaccharidesLoop of HenleMaleMice, Inbred C57BLMice, KnockoutPerfusionPhosphatidylinositol 3-KinasePhosphoinositide-3 Kinase InhibitorsPhosphorylationAdaptor Proteins, Vesicular TransportBicarbonatesExtracellular Signal-Regulated MAP KinasesLipid ALipopolysaccharidesmonophosphoryl lipid APhosphatidylinositol 3-KinasePhosphoinositide-3 Kinase InhibitorsProtein Kinase InhibitorsProto-Oncogene Proteins c-aktTicam1 protein, mouseTlr4 protein, mouseToll-Like Receptor 4kidneyLPSmonophosphoryl lipid AsepsisToll-like receptor 4

Identifiers

PMID28356284
PMCPMC5538844
OpenAlexW2598634929

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.